At ~$480, Lockheed Martin sits at the centre of global defence spending. Record backlogs, geopolitical tailwinds, and a fortress cash flow profile. But the ethical screen fails. Weapons are weapons.
Lockheed Martin is the world’s largest defence contractor, generating approximately $70 billion in annual revenue across four segments: Aeronautics (F-35, F-16, C-130), Missiles and Fire Control (HIMARS, PAC-3, JASSM), Rotary and Mission Systems (Sikorsky helicopters, radar systems), and Space (Orion, GPS satellites, hypersonics). The F-35 programme alone accounts for roughly 27% of revenue.
The geopolitical environment has transformed the defence business. NATO member states are increasing defence spending toward 2-3% of GDP targets. European rearmament following the Ukraine conflict has created a demand surge for US-made weapons systems. The Taiwan Strait tensions have driven a Pacific capability build-up. Lockheed’s backlog exceeds $160 billion, representing approximately 2.3 years of revenue visibility.
The challenge is execution. Defence manufacturing is constrained by supply chain bottlenecks, skilled labour shortages, and fixed-price contracts that squeeze margins when costs escalate. Lockheed’s operating margins have compressed from 14%+ to approximately 11% as these pressures bite. The revenue visibility is excellent. The margin trajectory is less certain.
The framework reads Lockheed in a markup regime. Institutional positioning in defence names is strongly positive, driven by the multi-year rearmament cycle across NATO and Indo-Pacific allies.
Defence spending cycles typically last 8-12 years. The current cycle began in 2022 and is arguably still in its early stages. European defence budgets are being reset structurally higher, not temporarily boosted. This creates a multi-year demand tailwind for US prime contractors that is partially but not fully priced.
The framework detects institutional positioning consistent with a “hold and add” approach rather than tactical trading. Long-duration holders are increasing allocations to defence, treating the sector as a structural theme rather than a geopolitical trade.
Lockheed Martin scores 32.8 on our ethical screening framework. This is a clear fail and the lowest score in this batch. The reasons are straightforward:
The 32.8 score is an unambiguous fail. Ethical screening criteria categorically exclude weapons manufacturers. This does not make Lockheed a bad company or a bad investment. It means it is incompatible with ethical investment mandates. We report this honestly rather than finding ways around it.
At ~$480, Lockheed trades at approximately 18x forward earnings, a premium to historical defence sector multiples of 14-16x, reflecting the structural demand improvement.
Forward P/E: ~18x | EV/EBITDA: ~15x | FCF Yield: ~4.5% | Dividend Yield: ~2.5%
Lockheed has increased its dividend for 22 consecutive years, with a 10-year CAGR above 8%. The buyback programme is substantial, with over $4 billion in annual repurchases. Combined shareholder returns exceed 7% annually, making Lockheed a reliable capital return story even at the elevated multiple.
The margin recovery is the key to sustained re-rating. If operating margins return to 13%+ (from current ~11%), earnings power expands meaningfully without requiring additional revenue growth. Supply chain normalisation and contract repricing are the paths to margin recovery.
Track LMT regime changes, ethical scores, and multi-factor convergence signals in real time.
Disclaimer: This case study is for informational and educational purposes only. It does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. All data is sourced from publicly available information and our proprietary analytical framework. Past performance and current framework readings do not guarantee future results. Always conduct your own due diligence and consult a qualified financial adviser before making investment decisions. Titan Protect is not a registered investment adviser.